Nyxoah SA (EBR:NYXH)
Belgium
· Delayed Price · Currency is EUR 5.62
+0.22 (4.07%)
At close: Apr 23, 2025, 5:30 PM CET
Nyxoah Revenue
In the year 2024, Nyxoah had annual revenue of 4.52M EUR with 3.98% growth. Nyxoah had revenue of 1.26M in the quarter ending December 31, 2024, a decrease of -30.76%.
Revenue
4.52M
Revenue Growth
+3.98%
P/S Ratio
46.53
Revenue / Employee
24.57K
Employees
184
Market Cap
210.34M
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| argenx SE | 2.17B |
| UCB SA | 6.15B |
| Financière de Tubize | 13.26K |
| Fagron NV | 871.96M |
| Ion Beam Applications | 465.75M |
| Hyloris Pharmaceuticals | 10.04M |
| Onward Medical | 1.70M |
| Sequana Medical NV | 433.50K |